An Army infantry veteran in his early 40s came to ValorSpine with a fusion recommendation for two lumbar discs after years of rucking, parachute jumps, and combat deployments. After 12 weeks of intra-annular fibrin injection plus structured rehab, his VAS pain dropped from 8 to 2, he returned to running and lifting, and he avoided lumbar fusion entirely. This case study documents the baseline, approach, and 24-month outcomes — and shows why fusion is rarely the only path forward, particularly for veterans considering non-surgical alternatives to spinal fusion.
Case Snapshot
- Patient: Anonymized male Army infantry veteran, early 40s, 12 years of service, multiple combat deployments and airborne operations
- Diagnosis: Symptomatic annular tears at L4-L5 and L5-S1 with degenerative disc disease confirmed on MRI
- Constraints: Wanted to avoid lumbar fusion, wanted to return to running and strength training, opposed long-term opioid use
- Approach: Intra-annular fibrin injection at both symptomatic levels, followed by 12 weeks of progressive rehab
- Outcomes: VAS pain 8 → 2 at 24 months, full return to physical training, no surgery, no chronic opioid prescriptions
Context and Baseline: A Veteran Told He Needed Fusion
The patient is an anonymized Army infantry veteran in his early 40s who served 12 years on active duty, including multiple combat deployments and several years on jump status. The mechanical history is the story most veteran spine cases share: years of rucking with 60–80 pound loads, repeated hard landings during parachute operations, and the cumulative spinal compression that accompanies a career in the infantry.
Veteran spine epidemiology backs up what this individual case shows. Per the U.S. Department of Veterans Affairs and Department of Defense pain data, 65.6% of veterans report pain in the past three months and veterans have a 40% greater rate of severe pain than non-veterans. More than 50% of soldiers experience low back pain during service, and low back pain is the number-one reason active-duty members seek medical care. In ex-military parachutists specifically, 84.7% show lumbar disc degeneration on imaging. This patient was not an outlier — he was the population.
By the time he arrived at ValorSpine, his pain had been progressing for more than three years. He rated daily pain at 7–8 out of 10 on the Visual Analog Scale (VAS), with episodic spikes during prolonged sitting, lifting, and after physical training. MRI documented annular tears at both L4-L5 and L5-S1 with disc desiccation and modest height loss, but no frank herniation requiring decompression and no neurologic deficit on exam.
The previous surgical consult had recommended a two-level lumbar fusion. This is consistent with broader patterns in the literature: roughly 40% of back surgeries do not achieve the patient’s desired outcome, revision rates can exceed 20% within 10 years, and adjacent segment disease affects many fusion patients. For a 42-year-old who wanted three to four more decades of active life, that risk profile was unacceptable. He was the textbook candidate to consider fibrin disc treatment instead of fusion.
Baseline Metrics at Intake
| Measure | Baseline Value |
|---|---|
| VAS pain (0–100 mm) | 78 mm (consistent with the 72.4 mm baseline reported in fibrin cohort literature) |
| Self-reported pain (0–10) | 7–8 daily, 9 with provocation |
| Imaging | Annular tears at L4-L5 and L5-S1; DDD; no herniation requiring decompression |
| Function | Unable to run, unable to lift > 25 lb, sitting tolerance < 30 minutes |
| Prior treatments | PT (partial benefit), epidural steroid injections (transient), NSAIDs, episodic opioids |
| Surgical recommendation | Two-level lumbar fusion (L4-S1) |
Approach: Why Intra-Annular Fibrin Injection Fit This Veteran
The treatment goal was direct: address the actual pain generators — the annular tears — rather than eliminate motion at the segments. Intra-annular fibrin injection is a biologic disc repair technique that delivers a fibrin sealant into the annular fissure to seal the tear, reduce inflammatory leakage onto the surrounding nerves, and create a scaffold that supports the body’s own healing response. It preserves disc height, preserves segmental motion, and does not require hardware.
The supporting evidence on this procedure aligns with the patient’s profile. Published cohort data show VAS pain scores improving from 72.4 mm at baseline to 33.0 mm at 104 weeks, with 70% patient satisfaction at two-year follow-up. In the failed-back-surgery population, 80% of patients reported positive outcomes after fibrin injection — useful corroboration even though this patient was treatment-naïve to surgery. By contrast, epidural steroid injections were rated “not effective” for chronic low back pain alone in the AAFP systematic review, which mirrored the patient’s transient response to his earlier injection course.
Three factors made this veteran a strong candidate:
- Discogenic pain, not pure mechanical instability. Imaging and provocation pattern pointed to the annular tears as the dominant source — exactly the pathology fibrin treatment targets.
- Preserved disc architecture. Modest height loss and no high-grade herniation meant biologic repair had structurally healthy tissue to work with.
- Strong rehab capacity. Military fitness baseline meant the patient could execute a demanding post-procedure rehab plan, which is the variable that most often separates good fibrin outcomes from average ones.
The decision tree we used with him is the same one we walk every patient through during the spine alternatives consultation — pain generator first, then biology, then rehab capacity, then patient values.
Implementation: The Procedure and Rehab Plan
Treatment was sequenced across one procedure day and 12 weeks of structured rehab.
Day of Procedure
- Outpatient setting, conscious sedation, fluoroscopic guidance
- Provocation discography to confirm L4-L5 and L5-S1 as the symptomatic levels
- Intra-annular fibrin injection at L4-L5 and L5-S1
- Total procedure time approximately 45 minutes; same-day discharge
Weeks 1–2: Protect
- Activity modification, no lifting > 10 lb, no running, no rucking
- Daily walking (10–20 minutes, flat ground)
- Sleep position coaching and ergonomic setup at home and work
Weeks 3–6: Restore
- Progressive PT focused on hip mobility, glute and core endurance, and dynamic spinal stability
- Reintroduction of moderate cardiovascular work (cycling, elliptical)
- Pain self-tracking on a 0–10 scale, with VAS re-measured at week 6
Weeks 7–12: Rebuild
- Graded return to running, starting with run-walk intervals
- Strength reintroduction: bodyweight to loaded, with hinge and squat patterns coached
- Reassessment of pain, function, and goals at week 12
Results: 24-Month Outcomes
The patient was tracked at 6 weeks, 12 weeks, 6 months, 12 months, and 24 months. Outcomes are summarized below.
| Measure | Baseline | 12 Weeks | 24 Months |
|---|---|---|---|
| VAS pain (0–100 mm) | 78 | 38 | 22 |
| Self-reported pain (0–10) | 7–8 | 3 | 2 |
| Sitting tolerance | < 30 min | > 90 min | Unrestricted |
| Lifting | < 25 lb | Bodyweight strength restored | Loaded squat and deadlift resumed |
| Running | None | 3-mile run-walk | 5–6 mile sustained runs |
| Opioid use | Episodic | None | None |
| Surgical status | Two-level fusion recommended | Avoided | Avoided |
The 56-point VAS reduction at 24 months exceeds the cohort-average improvement reported in the published fibrin literature (72.4 mm → 33.0 mm at 104 weeks). The patient’s strong rehab adherence is the most plausible reason his outcome outperformed the cohort mean.
From a quality-of-life perspective, the more important outcome is what surgery he did not have. He avoided two-level fusion, the 3–6+ month recovery window that procedure typically requires, the 20%+ revision rate over a decade, and the long-term adjacent-segment-disease risk that increasingly drives second and third surgeries.
Lessons Learned
- Pain generator confirmation matters more than imaging severity. The annular tears, not the disc height loss, drove this patient’s symptoms. Provocation discography aligned the treatment to the actual source.
- Rehab determines the ceiling. Fibrin injection creates the biological window for healing. The 12-week structured program is what cashed that window in. Veterans with strong baseline fitness convert that window into outsized gains.
- Fusion is rarely the only option. Nearly 1 in 5 patients told they need spine surgery decline it, and the data on conservative and biologic alternatives supports that decision more often than the surgical pathway acknowledges.
- Multilevel disease does not automatically mean multilevel surgery. Treating both symptomatic discs biologically — at the same session — produced a durable result without hardware.
Transparency: What We Would Refine
Three things we would do differently or want patients to know up front:
- Earlier imaging review with the patient. This veteran came in already convinced fusion was inevitable. A clearer walkthrough of his MRI in the first visit — not the second — would have shortened the decision timeline.
- Front-loaded rehab coaching. The patient’s strong outcome was rehab-driven. Patients with weaker baseline fitness need more hands-on PT in weeks 1–6, and we now build that in by default.
- Single-case data is not population data. This patient outperformed the cohort mean. Reasonable patient expectations should anchor on the published cohort numbers — VAS 72.4 → 33.0 at 104 weeks and 70% satisfaction at 2+ years — not on a single result.
How This Case Fits the Broader Treatment Landscape
For readers comparing options, this case sits inside a wider landscape that includes physical therapy, PRP (~47% of patients achieve ≥50% pain relief at 6 months), spinal decompression (~36.8% sustained improvement at 6 months), and surgery. The pillar resource on spinal fusion alternatives walks through each option and where it fits. For veterans specifically — who file an estimated 25% of VA musculoskeletal claims for back pain — biologic disc repair and conservative care should be evaluated before any fusion conversation begins.
Frequently Asked Questions
Is intra-annular fibrin injection appropriate for veterans with multilevel disc disease?
Yes, when the symptomatic levels are confirmed by imaging and provocation testing and the discs retain enough structural integrity to support biologic repair. This case treated two symptomatic levels at the same session with durable 24-month outcomes. Multilevel disease does not automatically require multilevel surgery.
How long is recovery from fibrin disc treatment compared with lumbar fusion?
Most patients return to light activity within 1–2 weeks and to full activity over 6–12 weeks, depending on baseline fitness. Lumbar fusion recovery averages 3–6 months or longer and carries a revision rate that can exceed 20% within 10 years. The fibrin pathway preserves motion and avoids hardware.
What pain reduction should a veteran expect from biologic disc repair?
Published cohort data report VAS pain scores improving from 72.4 mm at baseline to 33.0 mm at 104 weeks and 70% patient satisfaction at two-year follow-up. In the failed-back-surgery subgroup, 80% of patients reported positive outcomes. Individual results vary based on imaging, rehab adherence, and baseline function.
Does fibrin disc treatment work if epidural steroid injections did not?
Often yes. The AAFP systematic review found epidural steroid injections “not effective” for chronic low back pain alone, because steroids treat inflammation rather than the underlying annular tear. Fibrin treatment targets the structural tear and the inflammatory leakage simultaneously, which is a different mechanism.
Is fusion ever the right answer?
Fusion has clear indications — gross instability, severe deformity, fracture, tumor, or progressive neurologic deficit. For discogenic pain from annular tears in a patient with preserved disc height and no instability, biologic disc repair and structured rehab usually deserve a trial first. Bring these alternatives up directly with your surgeon before consenting to fusion.
Sources and Further Reading
- U.S. Department of Veterans Affairs and Department of Defense — veteran pain prevalence and severity data
- American Academy of Family Physicians — systematic review of epidural steroid injections for chronic low back pain
- Peer-reviewed clinical literature on intra-annular fibrin injection — 104-week VAS outcomes and 2-year satisfaction data
- National Institute of Neurological Disorders and Stroke — overview of low back pain pathophysiology and treatment options
- Journal of Neurosurgery — long-term reoperation and adjacent-segment-disease rates after lumbar fusion
- Published cohort data on platelet-rich plasma (PRP) for discogenic low back pain
Take the Next Step
Veterans deserve specialized spine care. Contact ValorSpine to learn about your treatment options.
